Aripiprazole decreases irritability in 12 out of 14 youth with autism spectrum disorders

J Child Adolesc Psychopharmacol. 2014 Aug;24(6):357-9. doi: 10.1089/cap.2013.0143. Epub 2014 May 14.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Antipsychotic Agents / therapeutic use*
  • Aripiprazole
  • Child
  • Child Development Disorders, Pervasive / drug therapy*
  • Child Development Disorders, Pervasive / physiopathology
  • Female
  • Humans
  • Irritable Mood / drug effects*
  • Male
  • Piperazines / therapeutic use*
  • Quinolones / therapeutic use*
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole